Reneo Pharmaceuticals Statistics
Total Valuation
RPHM has a market cap or net worth of $58.49 million. The enterprise value is -$23.44 million.
Market Cap | 58.49M |
Enterprise Value | -23.44M |
Important Dates
The last earnings date was Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RPHM has 33.42 million shares outstanding. The number of shares has increased by 33.49% in one year.
Shares Outstanding | 33.42M |
Shares Change (YoY) | +33.49% |
Shares Change (QoQ) | -0.38% |
Owned by Insiders (%) | 3.08% |
Owned by Institutions (%) | 88.26% |
Float | 8.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.72 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.83, with a Debt / Equity ratio of 0.01.
Current Ratio | 29.83 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.80% and return on invested capital (ROIC) is -93.12%.
Return on Equity (ROE) | -67.80% |
Return on Assets (ROA) | -60.10% |
Return on Capital (ROIC) | -93.12% |
Revenue Per Employee | n/a |
Profits Per Employee | -$8.84M |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.71% in the last 52 weeks. The beta is 0.23, so RPHM's price volatility has been lower than the market average.
Beta (1Y) | 0.23 |
52-Week Price Change | -77.71% |
50-Day Moving Average | 1.69 |
200-Day Moving Average | 4.14 |
Relative Strength Index (RSI) | 54.03 |
Average Volume (30 Days) | 278,346 |
Short Selling Information
The latest short interest is 3.07 million, so 9.19% of the outstanding shares have been sold short.
Short Interest | 3.07M |
Short Previous Month | 2.94M |
Short % of Shares Out | 9.19% |
Short % of Float | 34.23% |
Short Ratio (days to cover) | 28.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -76.50M |
Pretax Income | -70.71M |
Net Income | -70.71M |
EBITDA | -70.26M |
EBIT | -70.71M |
Earnings Per Share (EPS) | -$2.18 |
Balance Sheet
The company has $82.84 million in cash and $907,000 in debt, giving a net cash position of $81.93 million or $2.45 per share.
Cash & Cash Equivalents | 82.84M |
Total Debt | 907,000 |
Net Cash | 81.93M |
Net Cash Per Share | $2.45 |
Equity / Book Value | 81.24M |
Book Value Per Share | 2.43 |
Working Capital | 81.11M |
Cash Flow
In the last 12 months, operating cash flow was -$75.65 million and capital expenditures -$49,000, giving a free cash flow of -$75.70 million.
Operating Cash Flow | -75.65M |
Capital Expenditures | -49,000 |
Free Cash Flow | -75.70M |
FCF Per Share | -$2.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RPHM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.49% |
Shareholder Yield | -33.49% |
Earnings Yield | -120.89% |
FCF Yield | -129.42% |
Analyst Forecast
The average price target for RPHM is $11.46, which is 554.86% higher than the current price. The consensus rating is "Buy".
Price Target | $11.46 |
Price Target Difference | 554.86% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |